Skip to main content
letter
. 2020 Jun 24;133(15):1882–1883. doi: 10.1097/CM9.0000000000000873

Figure 1.

Figure 1

Serum zinc-α2-glycoprotein levels in the study population. (A) Serum zinc-α2-glycoprotein concentrations in control subjects (n = 140) and NAFLD patients (n = 168). (B) Serum zinc-α2-glycoprotein levels in different NAFLD severity. (C) Percentage of NAFLD according to quartiles of serum zinc-α2-glycoprotein. Values are given as mean ± standard deviation. NAFLD: Non-alcoholic fatty liver disease; ZAG: Zinc-α2-glycoprotein.